Skip to main content

Annexin A2 (ANXA2) regulates the transcription and alternative splicing of inflammatory genes in renal tubular epithelial cells



Renal inflammation plays a crucial role during the progression of Chronic kidney disease (CKD), but there is limited research on hub genes involved in renal inflammation. Here, we aimed to explore the effects of Annexin A2 (ANXA2), a potential inflammatory regulator, on gene expression in human proximal tubular epithelial (HK2) cells. RNA-sequencing and bioinformatics analysis were performed on ANXA2-knockdown versus control HK2 cells to reveal the differentially expressed genes (DEGs) and regulated alternative splicing events (RASEs). Then the DEGs and RASEs were validated by qRT-PCR.


A total of 220 upregulated and 171 downregulated genes related to ANXA2 knockdown were identified. Genes enriched in inflammatory response pathways, such as interferon-mediated signaling, cytokine-mediated signaling, and nuclear factor κB signaling, were under global transcriptional and alternative splicing regulation by ANXA2 knockdown. qRT-PCR confirmed ANXA2-regulated transcription of chemokine gene CCL5, as well as interferon-regulating genes ISG15, IFI6, IFI44, IFITM1, and IRF7, in addition to alternative splicing of inflammatory genes UBA52, RBCK1, and LITAF.


The present study indicated that ANXA2 plays a role in inflammatory response in HK2 cells that may be mediated via the regulation of transcription and alternative splicing of inflammation-related genes.


Chronic kidney disease (CKD) remains a major public health problem with limited available treatments [1]. A growing number of researches suggest that inflammation plays an important role in CKD [2, 3]. Inflammation in CKD is a complex network of interactions between kidney inherent cells and immune cells, accompanied by the recruitment of circulating monocytes, lymphocytes, and neutrophils [3]. Inflammatory pathways and signaling molecules, such as nuclear factor κB (NF-κB), monocyte chemoattractant protein-1, transforming growth factor β, interferon-γ (IFN-γ), tumor necrosis factor-α (TNF-α), and platelet-derived growth factor were found activated during CKD [4,5,6,7]. While several anti-inflammatory factors were found attenuated in CKD, such as interleukin (IL)-10 and bone morphogenetic protein-7 [7,8,9]. Restoration of the balance between pro- and anti-inflammatory signaling pathways is considered as a potential approach to treat CKD [7,8,9].

In this regard, the exploration of key upstream modulators in the kidney inflammation network has taken center stage. Annexin A2 (ANXA2), a 36-kD protein belongs to the annexin family, has been connected to a vast array of cellular functions, such as endocytosis, exocytosis, membrane domain organization, and translational regulation through RNA binding [10, 11]. Recent studies have proposed that ANXA2 plays a role in inflammation [12]. By modulating immunosuppressive responses, ANXA2 has been implicated in the process of tumor metastasis [13]. Furthermore, NLRP3 inflammasome activation was found elevated in dendritic cells of ANXA2-KO mice [14], as well as release of pro-inflammatory cytokines and superoxide [15, 16]. These revealed the anti-inflammatory role of ANXA2. However, the opposite function of ANXA2 in inflammatory reactions has also been reported. In rheumatoid arthritis, ANXA2 was believed to act as a pro-inflammatory actor by inducing expression of inflammatory cytokines TNF-α, IL-1β, and IL-6 [17]. Upregulation of ANXA2 had also been reported to accelerate fibroblast proliferation and fibrosis in several immune-mediated diseases [18]. The different roles of ANXA2 in inflammatory response, anti-inflammation, and pro-inflammation may depend on microcirculation. These findings revealed a strong correlation between ANXA2 and inflammatory system. However, there is a scarcity of research focusing on ANXA2 and kidney-related inflammation.

Besides regulating mRNA transcription, ANXA2 was also reported to have multiple roles in post-transcriptional regulation of gene expression [19, 20]. But the specific mechanisms remain to be studied. The significance of alternative splicing in post-transcriptional regulation has been found in many types of RNA-binding proteins, as the development of high-throughput sequencing technology [21] . Aa a RNA-binding protein with a wide range of interactions [11], ANXA2 might have potential roles in splicing regulation, which deserves to be deeply investigated. In the present study, we aim to explore whether ANXA2 had a modulatory effect on kidney inflammation. Through RNA-sequencing (RNA-seq) analysis, it would reveal whether ANXA2 regulates the expression and alternative splicing of key inflammatory response genes in renal tubular epithelial cells.


RNA-seq data summary and exploration of DEGs

To explore ANXA2-mediated transcriptional regulation, ANXA2 expression was knocked down using shRNA in HK2 cells. RNA-seq experiments were performed in ANXA2 knockdown (shANXA2, n = 3) and control samples (shCtrl, n = 3). As shown in Fig. 1A, the efficacy of ANXA2 knockdown was assessed by qRT-PCR. ANXA2 knockdown and control cells were used to construct cDNA libraries for sequencing on an Illumina HiSeq X Ten platform. The sequencing data were reviewed to ensure their reliability (shown in Supplementary Material Table 1). A total of 76.8 ± 7.0 M raw reads per sample were generated and 75.2 ± 8.0 M clean reads per sample were retained by the removal of adaptors and contaminating sequences. Among these, 70.2 ± 7.5 M were paired-end reads per sample, and an average of 67.8 ± 7.4 M read pairs per sample were aligned to the human genome. Gene and transcript quantifications were reassessed using Cufflinks [22], to compare gene expression patterns between individuals. FPKM values were then calculated. Using criteria of log2 fold change (>1 or <-1) and false discovery rate (FDR) of < 0.05 with the edgeR package, 220 upregulated and 171 downregulated genes related to ANXA2 knockdown were identified. A volcano plot was constructed to display the DEGs that were significantly associated with ANXA2 knockdown (shown in Fig. 1B). We found the DEGs that showed consistent expression patterns in three replicates by plotting a hierarchical clustering heatmap, and the shANXA2 samples were clearly separated from shCtrl samples (shown in Fig. 1C). The datasets generated and/or analysed during the current study are available in the GEO database, submission number GSE159360 (

Fig. 1
figure 1

Differentially expressed genes (DEGs) in shANXA2 and shCtrl HK2 cells. A The level of ANXA2 mRNA expression by qRT-PCR in shCtrl vs shANXA2 cells. (n = 3, ***P < 0.001, calculated using the student’s t-test). B Volcano plots indicate gene expression in shCtrl vs shANXA2 cells. Genes with significant differential expression are shown in red (up-regulated) or blue (down-regulated), and genes that were not significantly differentially expressed are shown in grey. Filtering criteria (log2 fold change >1 or <-1 and FDR < 0.05) was set as the threshold to determine the DEGs. C Heatmaps for DEGs of shCtrl vs shANXA2 cells

ANXA2 regulates the expression of genes enriched in inflammatory response in HK2 cells

In order to explore the functions of genes regulated by ANXA2 in HK2 cells, KEGG and GO pathway analyses of DEGs from shANXA2 vs. shCtrl were performed. In the GO pathway analysis of biological process, significant enrichment of upregulated genes in shANXA2 cells was found in type I interferon-mediated signaling pathway, cytokine-mediated signaling pathway, and interferon-gamma-mediated signaling pathway, with P value less than 0.05 (shown in Fig. 2A). The GO results of biological process in downregulated genes of shANXA2 cells was omitted since no enrichment was found. As for GO results of cellular component and and molecular function, upregulated genes in shANXA2 cells related mainly to cytoplasm, protein binding and ATP binding, while downregulated genes might enrich in membrane, cytoplasm and protein binding (shown in Fig. S1). In the KEGG pathway analysis, the upregulated genes in the ANXA2 knockdown cells were mainly associated with inflammatory pathways, including influenza A, herpes simplex infection, measles, RIG-I-like receptor signaling pathway, hepatitis C (shown in Fig. 2B). The downregulated genes were enriched in pathways such as the cell adhesion molecules and cAMP signaling pathway (shown in Fig. 2C).

Fig. 2
figure 2

ANXA2 regulated inflammatory gene mRNA and protein expression in HK2 cells. A Top ten GO biological processes terms enriched by upregulated DEGs in shANXA2 cells vs shCtrl cells. B Top ten KEGG functional pathways enriched by upregulated DEGs in shANXA2 cells vs shCtrl cells. C Top ten KEGG functional pathways enriched by downregulated DEGs in shANXA2 cells vs shCtrl cells. D Validation of mRNA expression of CCL5, IFI6, IFI44, IFITM1,and LTB by qRT-PCR assay. E Validation of mRNA expression of IRF7 and ISG15 by qRT-PCR assay. F Representative images showing protein levels of ANXA2, CCL5, IFI6, IFI44, IFITM1, LTB, IRF7 and ISG15 in LV-shANXA2 group vs LV-shCtrl group. Results are represented as mean ± SD.(n = 3,* P < 0.05, **P < 0.01, ***P < 0.001, calculated using the student’s t-test)

In order to verify the RNA-seq results, qRT-PCR analysis was performed on seven upregulated DEGs, including CCL5, IFI6, IFI44, IFITM1, LTB, IRF7, and ISG15. The selected genes were enriched in cell adhesion, interferon-mediated signaling, inflammatory response pathways of the KEGG or GO analyses, and the FPKM of these genes was higher than 1 in at least one sample. The results of this experiment are presented in Fig. 2D and E. A statistically significant increase was observed in CCL5, IFI6, IFI44, IFITM1, LTB, IRF7, and ISG15 mRNA expression in shANXA2 samples vs in shCtrl samples, in agreement with the RNA-seq analysis.

Protein levels of inflammatory genes in stable cell lines with low ANXA2 expression and with ANXA2 overexpression

To further verify the effect of ANXA2 on the DEGs, stable cell lines with low ANXA2 expression and with ANXA2 overexpression were established. Western blot was performed to detect the corresponding protein levels of the DEGs. As shown in Fig. 2F, the protein level of ANXA2 was decreased in LV-shANXA2 group vs LV-shCtrl group. Protein levels of CCL5, IFI6, IFI44, IFITM1, LTB, IRF7, and ISG15 were increased by silencing ANXA2, which was similar to the effect of ANXA2 on gene expression of these DEGs. Additionally, overexpression of ANXA2 led to lower protein levels of these DEGs (shown in Fig. S2).

RNA-seq analysis of ANXA2-regulated alternative splicing in HK2 cells

The other key aim of this study was to gain insight into the role of ANXA2 on alternative splicing regulation. Therefore, we further used transcriptome sequencing data to observe the ANXA2-dependent RASEs in HK2 cells. RASEs were analyzed using ABLas software. We detected 18,491 known RASEs in the model gene that we designated in the reference genome, along with 52,724 novel RASEs, excluding intron retention (shown in Supplementary Material Table 2). When we applied a stringent cutoff of P<0.05 to identify high-confidence RASEs, a total of 699 RASEs were detected when comparing shANXA2 vs. shCtrl. ANXA2-regulated RASEs were summarized in Supplementary Material Table 3 and Fig. 3A, including 131 alternative 3′ splice sites (A3SS), 140 alternative 5′ splice sites (A5SS), 125 examples of exon skipping (ES), 70 cassette exons, 22 mutually exclusive 5′ untranslated regions (UTRs) (5pMXE), 15 mutually exclusive 3′ UTRs (3pMXE), 26 mutually exclusive exons (MXE), 144 examples of intron retention (IR), 16 examples of alternative 5′ splice site & exon skipping (A5SS & ES), and 10 examples of alternative 3′ splice site & exon skipping (A3SS & ES). Coupled to the transcription data, there were only 2 genes under significant transcriptional control overlapped with those under splicing control (shown in Fig. 3B). To identify the pathways in which the RASEs were mainly involved, GO and KEGG enrichment analyses were conducted. The alternative splicing genes were enriched in positive regulation of cell adhesion, positive regulation of I-κB kinase/NF-κB cascade, and cell-cell junction in GO analysis (shown in Fig. 3C). Though the KEGG analysis showed some possible enrichment, the large P value suggested it might not be significant enough (shown in Fig. 3D).

Fig. 3
figure 3

Identification and functional analysis of ANXA2-regulated splicing events. A Classification of regulated alternative splicing events (RASE) induced by ANXA2. B Analysis of the overlap between ANXA2-regulated DEGs and regulated alternative splicing genes (RASG). C Top ten GO biological processes terms of ANXA2-regulated alternative splicing genes. D Top ten KEGG functional pathways of ANXA2-regulated alternative splicing genes

ANXA2-regulated alternative splicing of key genes in inflammation signaling pathways

To validate ANXA2-related RASEs detected by RNA-seq in HK2 cells, ten RASEs were selected for qRT-PCR analysis. Out of these ten tested events, five RASEs validated by qRT-PCR were consistent with the RNA-seq results. These five RASEs located in five relevant genes (MAP3K3, UBA52, LITAF, RBCK1, and NOD1). Figure 4 shows the three RASEs located in three key genes (LITAF, UBA52, and RBCK1) involved in inflammation pathways. These results confirmed the ANXA2-regulated RASEs identified by ABLas analysis of RNA-seq results and showed that ANXA2 was involved in alternative splicing of inflammatory genes in renal tubular epithelial cells.

Fig. 4
figure 4

Validation of ANXA2-regulated alternative splicing events in key genes of inflammation pathways. A RASEs in LITAF. B RASEs in UBA52. C RASEs in RBCK1. The altered ratio of alternative splicing (AS) events in RNA-seq was calculated using the formula: AS junction reads / (AS junction reads + Model junction reads); while the altered ratio of AS events in qRT-PCR was calculated using the formula: AS transcripts level / Model transcripts level. (n = 3, *P < 0.05,**P < 0.01, ***P < 0.001, calculated using the student’s t-test)


The purpose of this study was to provide new insights into the regulation of ANXA2 on gene expression in proximal tubular cells using HK2 cells. The expression of ANXA2 in HK2 cells was silenced using shRNA. Through genome-wide transcriptional and RASE analysis of shANXA2 and shCtrl HK2 cells using RNA-seq, it was shown that ANXA2 regulated the expression and RASE of inflammatory response genes.

Transcriptional analysis identified 220 upregulated and 171 downregulated genes related to ANXA2 knockdown. DEG analysis indicated that these DEGs were enriched in multiple KEGG pathways and GO functional terms, which was consistent with the reported function of ANXA2 in signal transduction, organismal development and metastasis [23, 24]. Interestingly, ANXA2-regulated genes were also enriched in inflammatory pathways, including influenza A, herpes simplex infection, measles, hepatitis C, type I interferon-mediated signaling pathway, cytokine-mediated signaling pathway, and interferon-gamma- mediated signaling pathway. This implied that ANXA2 possibly had an important regulatory function on inflammatory response in proximal tubular cells.

During the evolution of kidney fibrosis, it was common that macrophages and T lymphocytes accumulated around the renal vasculature and throughout the interstitium of the kidney [25]. These infiltrating cells generated a milieu of pro-inflammatory molecules that exacerbate tissue injury [26]. CCL5 was reported to recruit mononuclear cells into injured tissues and some studies have shown that CCL5 dysregulation played a key role in driving the increase and activation of inflammatory macrophages in kidney disease [27]. In this study, both RNA-seq analysis and qRT-PCR showed that CCL5 was up-regulated in ANXA2 knockdown HK2 cells. This indicated that ANXA2 might regulate renal inflammation by regulating the expression of CCL5 in proximal tubular cells.

Both type I interferon and IFN-γ signaling was involved in inflammatory injury, viral infection, cell growth regulation, apoptosis, and immune responses [28, 29]. A previous study showed that a type I IFN-dependent transcript, ISG15 dysregulation, was involved in the pathogenesis of renal inflammation [30]. Furthermore, some studies have shown that IFN-γ-inducible protein 10 was strongly involved in the development of renal diseases [31, 32]. These findings suggested that IFN signaling might be associated with the pathogenesis of various kidney diseases and further study was desirable to discover future therapeutic strategies for kidney disease. In this study, we validated certain DEGs and discovered some elevated IFN-response genes, including ISG15, IFI6, IFI44, IFITM1, and IRF7 in HK2 cells from the ANXA2 knockdown group compared with the control group. This indicated that ANXA2 might regulate renal inflammation by regulating the expression of IFN-response genes.

Additionally, the current study determined that ANXA2 also regulated alternative splicing of inflammatory genes, such as genes enriched in NF-κB pathways. NF-κB is one of the most important transcription factors involved in the pathophysiology of renal inflammation and fibrosis. In non-stimulated cells, NF-κB dimers are sequestered by a family of inhibitors known as IκBs (inhibitors of NF-κB). The activation of NF-κB depends on degradation of IκBs by IκB kinase (IKK), which involves signal assembling process of connecting upstream signal generation apparatuses to IKK using ubiquitin modifications. RBCK1, MAP3K3, and NOD1 were all believed to play important roles during the assembling process [33,34,35]. Here, it was demonstrated that ANXA2 regulated alternative splicing of these three signaling molecules, implying that ANXA2 might regulate inflammatory response partly by regulating NF-κB signaling pathways. Interestingly, a previous study verified the important role of ANXA2 in activating NF-κB signaling pathways in adipose tissue [36]. In addition, we also validated the regulatory effect of ANXA2 on RASEs in the gene LITAF, which was proved to be a key gene in the inflammatory response [37]. Herein, we demonstrated the regulatory effect of ANXA2 on alternative splicing of key genes in inflammatory pathways in proximal tubular cells.


In this study, we successfully applied RNA-seq technology to demonstrate that ANXA2 regulated gene transcription and alternative splicing, which was consistent with its reported role as a RNA-binding protein. We showed that ANXA2 regulated transcription, alternative splicing and protein expression of genes involved in inflammatory response in HK2 cells. Our results underlined that the well-known multifunctional protein ANXA2 might play a key role in kidney inflammation. More detailed information and the underlying molecular mechanism of ANXA2 on kidney inflammation need to be further elucidated. This might contribute to precise understanding of signaling networks directing kidney inflammation, and potentially ANXA2-targeted therapies.


Plasmid construction

ANXA2-specific short hairpin RNA (shRNA) was designed using the free software OptiRNA. The silence sequence was TGAGGGTGACGTTAGCATTAC and was synthesized by TianyiHuiyuan Biotechnology Co., LTD (Beijing, China). The vector pGFP-B-RS (OriGene, Rockville, MD, USA) was digested using HindIII (NEB, Beijing, China) and BamHI (NEB, Beijing, China) and purified with a Qiagen column kit (Qiagen, Dusseldorf, Germany). Sense and antisense strands were annealed to the shRNA and inserted to the processed vector by T4 DNA Ligase (NEB, Beijing, China). Escherichia coli (DH5α, ECOS, fye607s) containing the plasmids were plated onto LB plates and incubated overnight at 37 °C. Colonies were screened by colony PCR (30 cycles) with universal primers. The interference sequence of shRNA was verified by Sanger sequencing.

Cell culture and transfections

Human proximal renal tubular epithelial (HK2) cells were obtained from Procell Life Science & Technology Co., Ltd. (Wuhan, Hubei, China). HK2 cells were cultured at 37 °C with 5% CO2 in Dulbecco’s modified Eagle’s medium contaning 100 U/mL penicillin, 100 μg/mL streptomycin and 10% fetal bovine serum. Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) was utilized to transfect plasmids into HK2 cells. Transfected HK2 cells were cultured for 48 h before quantitative real-time PCR (qRT-PCR) analysis. ANXA2 primers: Forward, ATGTTCCCAAGTGGATCAGC and reverse, ACAGGGGCTTGTTCTGAATG. The primers were synthesized by TianyiHuiyuan Biotechnology Co., LTD (Beijing, China). Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was adopted as internal standard and gene expression was evaluated by the 2-ΔΔCq method.

Establishment of stable transfectants

ANXA2-specific shRNA sequence was cloned into the lentiviral vector FV023 (Fubio, Suzhou, China) to construct stable cell lines with low ANXA2 expression(LV-shANXA2 group), while the control group was loaded with a scramble RNA sequence (LV-shCtrl group). ANXA2 sequence were cloned into lentiviral vector FV026 (Fubio,Suzhou,China) to generate stable cell lines with ANXA2 overexpression (LV-OE-ANXA2 group), with empty FV026 as control (LV-OE-Ctrl). HK2 cells at 70–80% confluence were infected by respective lentiviruses with the multiplicity of infection (MOI) of 100. After 48 h post infection, positive HK2 cells were selected with 2 μg/mL puromycin (Sigma, USA) for 14 days. Western blot was then used to detect ANXA2 protein levels of each group.

RNA extraction and sequencing

Total RNA was extracted using TRIzol (Invitrogen, Carlsbad, CA, USA), followed by RQ1 DNase (Promega, Madison, WI, USA) treatment to eliminate DNA. Absorbance at 260 nm/280 nm (A260/A280), along with 1.5% agarose gel electrophoresis were performed to standardize the quality and integrity of RNA samples. For RNA-seq library preparation, oligo(dT)-conjugated magnetic beads (Invitrogen, Carlsbad, CA, USA) were adopted to purify the samples and 1 μg of each RNA sample underwent reverse transcription into cDNA using the PrimeScript™ RT Reagent Kit (Takara, Dalian, China). Libraries for high-throughput sequencing were prepared according to the manufacturer’s instructions and applied to the Illumina HiSeq X Ten system for 150-nt paired-end sequencing.

Bioinformatics analysis

Raw reads were filtered to remove the adaptors, PolyN reads, short reads less than 16 nt, and low-quality bases, using FASTX-Toolkit (version 0.0.13). Clean reads were then aligned to the GRCh38 genome using TopHat2 software [38] with four mismatches. Uniquely mapped reads were used to calculate the reads number and FPKM value (fragments per kilobase per million mapped reads). Raw read counts were used as input in edgeR to discriminate the differentially expressed genes (DEGs) [39]. Genes with lower FPKM than 0.1 were not considered for further analysis, while genes with considerable log2 fold change (>1 or <-1) and P value (P < 0.05) were identified as DEGs. Gene Ontology (GO, and Kyoto Encyclopedia of Genes and Genomes (KEGG, analyses were performed to explore the potential function of DEGs. Bioinformatics resources were obtained from the database for annotation, visualization, and integrated discovery (DAVID) bioinformatics resources ( ABLas pipeline was used to calculate the regulated alternative splicing events (RASEs) [40]. A P-value of < 0.05 and a RASE ratio of > 0.2 was set as the threshold for RASE detection.

Validation of DEGs and RASEs

To validate the DEGs and RASEs, expression of several genes were evaluated by qRT-PCR on a Bio-Rad S1000 thermal cycler with Bestar SYBR Green RT-PCR Master Mix (DBI Bioscience, Shanghai, China). Supplementary Material Table 4 presented the primers for DEGs and Supplementary Material Table 5 for RASEs. The PCR procedure was denaturing at 95 °C for 10 min, 40 cycles of denaturing at 95 °C for 15 s, annealing and extension at 60 °C for 1 min. For each sample, three experimental replicates were performed.

Western blot

Protein samples were extracted from cultured HK2 cells with RIPA lysis buffer (Beyotime, China) with the presence of 1 mM phenylmethane-sulfonyl fluoride (PMSF). Equal amount of each sample was electrophoresed by SDS-PAGE gels and then transferred to polyvinylidene difluoride membranes (PVDF, Millipore, USA). The membranes were incubated overnight separately with specific rabbit primary antibodies after 2 h of blocking. Anti-rabbit secondary antibody conjugated to horseradish peroxidase (Boster, BA1054, Wuhan, China) was incubated with the membranes for 1 h. Primary antibodies anti-ANXA2(AF 5420), anti-CCL5 (DF5151), anti-IFI6 (DF10115), anti-IFITM1 (DF 2513), anti-LTB (DF 3243), anti-IRF7 (DF7503), and ISG15 (DF6316) were from Affinity Biosciences (Cincinnati, OH, USA). Other primary antibodies included anti-IFI44 (Proteintech, 27,233–1-AP,Wuhan, China) and anti-actin (Boster, BM3873, Wuhan, China).

Statistical analysis

All values were presented as mean ± SD. For comparison, the significance of differences between means was determined using the Student’s t-test. A P value of < 0.05 was regarded as statistically significant.

Availability of data and materials

The datasets generated and/or analysed during the current study are available in the GEO database (, accession number GSE159360).



Annexin A2


Chronic kidney disease


Differentially expressed genes


Regulated alternative splicing events


Nuclear factor κB




Tumor necrosis factor-α




Short hairpin RNA


Gene Ontology


Kyoto Encyclopedia of Genes and Genomes


Database for annotation, visualization, and integrated discovery


Fragments per kilobase of exon model per million fragments mapped


False discovery rate


Inhibitors of NF-κB


IκB kinase


Regulated alternative splicing genes


  1. Luyckx VA, Cherney DZI, Bello AK. Preventing CKD in developed countries. Kidney Int Rep. 2020;5(3):263–77.

    Article  Google Scholar 

  2. Anders HJ. Four danger response programs determine glomerular and tubulointerstitial kidney pathology: clotting, inflammation, epithelial and mesenchymal healing. Organogenesis. 2012;8(2):29–40.

    Article  Google Scholar 

  3. Xiang H, Zhu F, Xu Z, Xiong J. Role of Inflammasomes in kidney diseases via both canonical and non-canonical pathways. Front Cell Dev Biol. 2020;8:106.

    Article  Google Scholar 

  4. Chen L, Yang T, Lu DW, Zhao H, Feng YL, Chen H, et al. Central role of dysregulation of TGF-beta/Smad in CKD progression and potential targets of its treatment. Biomed Pharmacother. 2018;101:670–81.

    Article  CAS  Google Scholar 

  5. Pedruzzi LM, Stockler-Pinto MB, Leite M Jr, Mafra D. Nrf2-keap1 system versus NF-kappaB: the good and the evil in chronic kidney disease? Biochimie. 2012;94(12):2461–6.

    Article  CAS  Google Scholar 

  6. Law BMP, Wilkinson R, Wang X, Kildey K, Lindner M, Rist MJ, et al. Interferon-gamma production by tubulointerstitial human CD56(bright) natural killer cells contributes to renal fibrosis and chronic kidney disease progression. Kidney Int. 2017;92(1):79–88.

    Article  CAS  Google Scholar 

  7. Lv W, Booz GW, Wang Y, Fan F, Roman RJ. Inflammation and renal fibrosis: recent developments on key signaling molecules as potential therapeutic targets. Eur J Pharmacol. 2018;820:65–76.

    Article  CAS  Google Scholar 

  8. Sziksz E, Pap D, Lippai R, Beres NJ, Fekete A, Szabo AJ, et al. Fibrosis related inflammatory mediators: role of the IL-10 cytokine family. Mediat Inflamm. 2015;2015:764641.

    Article  Google Scholar 

  9. Li RX, Yiu WH, Tang SC. Role of bone morphogenetic protein-7 in renal fibrosis. Front Physiol. 2015;6:114.

    PubMed  PubMed Central  Google Scholar 

  10. Luo M, Hajjar KA. Annexin A2 system in human biology: cell surface and beyond. Semin Thromb Hemost. 2013;39(4):338–46.

    Article  CAS  Google Scholar 

  11. Filipenko NR, MacLeod TJ, Yoon CS, Waisman DM. Annexin A2 is a novel RNA-binding protein. J Biol Chem. 2004;279(10):8723–31.

    Article  CAS  Google Scholar 

  12. Hajjar KA. The biology of Annexin A2: from vascular fibrinolysis to innate immunity. Trans Am Clin Climatol Assoc. 2015;126:144–55.

    PubMed  PubMed Central  Google Scholar 

  13. Chao PZ, Hsieh MS, Cheng CW, Hsu TJ, Lin YT, Lai CH, et al. Dendritic cells respond to nasopharygeal carcinoma cells through annexin A2-recognizing DC-SIGN. Oncotarget. 2015;6(1):159–70.

    Article  Google Scholar 

  14. Scharf B, Clement CC, Wu XX, Morozova K, Zanolini D, Follenzi A, et al. Annexin A2 binds to endosomes following organelle destabilization by particulate wear debris. Nat Commun. 2012;3:755.

    Article  Google Scholar 

  15. Li R, Tan S, Yu M, Jundt MC, Zhang S, Wu M. Annexin A2 regulates autophagy in Pseudomonas aeruginosa infection through the Akt1-mTOR-ULK1/2 signaling pathway. J Immunol. 2015;195(8):3901–11.

    Article  CAS  Google Scholar 

  16. He S, Li X, Li R, Fang L, Sun L, Wang Y, et al. Annexin A2 modulates ROS and Impacts inflammatory response via IL-17 signaling in Polymicrobial Sepsis mice. PLoS Pathog. 2016;12(7):e1005743.

    Article  Google Scholar 

  17. Haridas V, Shetty P, Sarathkumar E, Bargale A, Vishwanatha JK, Patil V, et al. Reciprocal regulation of pro-inflammatory Annexin A2 and anti-inflammatory Annexin A1 in the pathogenesis of rheumatoid arthritis. Mol Biol Rep. 2019;46(1):83–95.

    Article  CAS  Google Scholar 

  18. Yi J, Zhu Y, Jia Y, Jiang H, Zheng X, Liu D, et al. The Annexin a2 promotes development in arthritis through neovascularization by amplification hedgehog pathway. PLoS One. 2016;11(3):e0150363.

    Article  Google Scholar 

  19. Vedeler A, Hollas H, Grindheim AK, Raddum AM. Multiple roles of annexin A2 in post-transcriptional regulation of gene expression. Curr Protein Pept Sci. 2012;13(4):401–12.

    Article  CAS  Google Scholar 

  20. Fähling M, Paliege A, Jönsson S, Becirovic-Agic M, Melville JM, Skogstrand T, et al. NFAT5 regulates renal gene expression in response to angiotensin II through Annexin-A2-mediated posttranscriptional regulation in hypertensive rats. Am J Physiol Ren Physiol. 2019;316(1):F101–12.

    Article  Google Scholar 

  21. Ule J, Blencowe BJ. Alternative splicing regulatory networks: functions, mechanisms, and evolution. Mol Cell. 2019;76(2):329–45.

    Article  CAS  Google Scholar 

  22. Trapnell C, Roberts A, Goff L, Pertea G, Kim D, Kelley DR, et al. Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and cufflinks. Nat Protoc. 2012;7(3):562–78.

    Article  CAS  Google Scholar 

  23. Liu Y, Myrvang HK, Dekker LV. Annexin A2 complexes with S100 proteins: structure, function and pharmacological manipulation. Br J Pharmacol. 2015;172(7):1664–76.

    Article  CAS  Google Scholar 

  24. Fatimathas L, Moss SE. Annexins as disease modifiers. Histol Histopathol. 2010;25(4):527–32.

    CAS  PubMed  Google Scholar 

  25. Andrade-Oliveira V, Foresto-Neto O, Watanabe IKM, Zatz R, Camara NOS. Inflammation in renal diseases: new and old players. Front Pharmacol. 2019;10:1192.

    Article  CAS  Google Scholar 

  26. Engel JE, Chade AR. Macrophage polarization in chronic kidney disease: a balancing act between renal recovery and decline? Am J Physiol Ren Physiol. 2019;317(6):F1409–13.

    Article  CAS  Google Scholar 

  27. Lee CP, Nithiyanantham S, Hsu HT, Yeh KT, Kuo TM, Ko YC. ALPK1 regulates streptozotocin-induced nephropathy through CCL2 and CCL5 expressions. J Cell Mol Med. 2019;23(11):7699–708.

    Article  CAS  Google Scholar 

  28. Barrat FJ, Crow MK, Ivashkiv LB. Interferon target-gene expression and epigenomic signatures in health and disease. Nat Immunol. 2019;20(12):1574–83.

    Article  CAS  Google Scholar 

  29. Kotenko SV, Rivera A, Parker D, Durbin JE. Type III IFNs: beyond antiviral protection. Semin Immunol. 2019;43:101303.

    Article  CAS  Google Scholar 

  30. Imaizumi T, Shimada T, Matsumiya T, Yoshida H, Watanabe S, Tsuruga K, et al. Interferon-stimulated gene 15, a type I interferon-dependent transcript, is involved in a negative feedback loop in innate immune reactions in human Mesangial cells. Nephron. 2016;132(2):144–52.

    Article  CAS  Google Scholar 

  31. Gao J, Wu L, Wang S, Chen X. Role of chemokine (C-X-C motif) ligand 10 (CXCL10) in renal diseases. Mediat Inflamm. 2020;2020:6194864.

    Google Scholar 

  32. El-Gohary A, Hegazy A, Abbas M, Kamel N, Nasef SI. Serum and urinary interferon-gamma-inducible protein 10 in lupus nephritis. J Clin Lab Anal. 2016;30(6):1135–8.

    Article  CAS  Google Scholar 

  33. Taminiau A, Draime A, Tys J, Lambert B, Vandeputte J, Nguyen N, et al. HOXA1 binds RBCK1/HOIL-1 and TRAF2 and modulates the TNF/NF-kappaB pathway in a transcription-independent manner. Nucleic Acids Res. 2016;44(15):7331–49.

    CAS  PubMed  PubMed Central  Google Scholar 

  34. Tang H, Lv W, Sun W, Bi Q, Hao Y. miR505 inhibits cell growth and EMT by targeting MAP3K3 through the AKTNFkappaB pathway in NSCLC cells. Int J Mol Med. 2019;43(3):1203–16.

    CAS  PubMed  Google Scholar 

  35. Huang W, Gou F, Long Y, Li Y, Feng H, Zhang Q, et al. High glucose and lipopolysaccharide activate NOD1- RICK-NF-kappaB inflammatory signaling in Mesangial cells. Exp Clin Endocrinol Diabetes. 2016;124(8):512–7.

    Article  CAS  Google Scholar 

  36. Wang Y, Cheng YS, Yin XQ, Yu G, Jia BL. Anxa2 gene silencing attenuates obesity-induced insulin resistance by suppressing the NF-kappaB signaling pathway. Am J Physiol Cell Physiol. 2019;316(2):C223–34.

    Article  CAS  Google Scholar 

  37. Ceccarelli S, Panera N, Mina M, Gnani D, De Stefanis C, Crudele A, et al. LPS-induced TNF-alpha factor mediates pro-inflammatory and pro-fibrogenic pattern in non-alcoholic fatty liver disease. Oncotarget. 2015;6(39):41434–52.

    Article  Google Scholar 

  38. Kim D, Pertea G, Trapnell C, Pimentel H, Kelley R, Salzberg SL. TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol. 2013;14(4):R36.

    Article  Google Scholar 

  39. Robinson MD, McCarthy DJ, Smyth GK. edgeR: a bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010;26(1):139–40.

    Article  CAS  Google Scholar 

  40. Xia H, Chen D, Wu Q, Wu G, Zhou Y, Zhang Y, et al. CELF1 preferentially binds to exon-intron boundary and regulates alternative splicing in HeLa cells. Biochim Biophys Acta Gene Regul Mech. 2017;1860(9):911–21.

    Article  CAS  Google Scholar 

Download references


Not applicable.


This study was supported by Hubei Provincial Natural Science Foundation (Grant No. 2020CFB683). The funding bodies played no role in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript.

Author information

Authors and Affiliations



JC and LC designed the study. JC and SX peformed the experiments, analysed the data and drafted the manuscript. YL and XY performed the data analysis. LC and XY drafted and revised the manuscript. All authors have read and approved the final manuscript.

Corresponding authors

Correspondence to Xujun Ye or Ling Chen.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare that have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1: Table 1.

Summary of RNA-seq reads used in the analysis.

Additional file 2: Table 2.

Known and novel splicing events detected using ABLas. aNumbers in this line indicate the unique RASEs identified from all four samples. Since many RASEs were detected in more than one sample, the numbers in this line are less than the sum of the four individual numbers. b Indicates the sum of all types of RASEs detected in each sample or all samples. c Indicates the known spliced junctions detected in each sample or all samples. RASEs, regulated alternative splicing events.

Additional file 3: Table 3.

Summary of ANXA2-regulated alternative splicing events.

Additional file 4: Table 4.

Primer sequences used in qRT-PCR experiments for DEG validation.

Additional file 5: Table 5.

Primer sequences used in qRT-PCR experiments for RASE validation.

Additional file 6: Fig. S1.

GO analysis of cellular component and molecular function of DEGs in shANXA2 vs shCtrl cells. (A) GO cellular component terms enriched by upregulated DEGs in shANXA2 cells vs shCtrl cells.(B) GO cellular component terms enriched by downregulated DEGs in shANXA2 cells vs shCtrl cells.(C) GO molecular function terms enriched by upregulated DEGs in shANXA2 cells vs shCtrl cells.(D) GO molecular function terms enriched by downregulated DEGs in shANXA2 cells vs shCtrl cells.

Additional file 7: Fig. S2.

Representative images showing protein levels of ANXA2, CCL5, IFI6, IFI44, IFITM1, LTB, IRF7 and ISG15 in LV-OE-ANXA2 group vs LV-OE-Ctrl group.

Additional file 8: Fig. S3.

Original images showing protein bands of ANXA2, CCL5, IFI6, IFI44, IFITM1, LTB, IRF7 and ISG15 in LV-shANXA2 group vs LV-shCtrl group, and in LV-OE-ANXA2 group vs LV-OE-Ctrl group.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chen, J., Liu, Y., Xia, S. et al. Annexin A2 (ANXA2) regulates the transcription and alternative splicing of inflammatory genes in renal tubular epithelial cells. BMC Genomics 23, 544 (2022).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: